Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations
Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a...
EGBOT
Thread
agreement
compounded
formulations
imprimis
proprietary